News about David Denton

Memo to self. 'PRIORITY: Time to shield savings and investments from the tentacles of the Labour government - and consider sale of second home and buy-to-let property.' It's a memo that you should pin on your fridge door if you have been able - and fortunate enough - to accumulate your own mini wealth fund to provide financial security in later life. Irrespective of the composition of your wealth portfolio - be it shares, a buy-to-let property, a second home or a holiday-let - Labour, greedy Labour, is after a chunky slice of it when you come to dispose of any of these assets.

One option for those planning to leave sizeable wealth to their loved ones, is to create a family investment company to manage and pass on their wealth to the next generation. This is Money sheds the light on whether creating a family investment company might be the right move for you to protect your families' inheritance.

The pharmaceutical giant told investors that it raised £885.6 million from selling 270 million Haleon shares at 328p each, reducing its shareholding in the company from 10.3 percent to 7.4 percent. When GSK and Pfizer spun off Haleon last year, the former held a 52.9 percent stake in the company, though the American drugmaker owned just under a fifth of the shares.

Joshua Schulte (pictured left), 34, was found guilty on eight espionage charges and one obstruction charge in connection with the so-called Vault 7 leak in federal court in July 2022. He now faces allegations that he owned and distributed thousands of photographs demonstrating rape and sexual abuse of children. Schulte moved from Washington, DC, to New York with him, according to federal prosecutors. Schulte has previously stated that the FBI framed him because of his work in the CIA. He will not be allowed to make that argument at trial.

Around 240 million shares in the consumer health company, which is equivalent to a 2.6 percent stake in the company. For a total gain of £804 million, GSK sold the shares at 335p per cent discount to Haleon's previous closing price. Haleon, which also manufactures Panadol painkillers and Centrum vitamins, was spun out of GSK in July last year, making it the largest European stock market IPO in more than a decade.

Pfizer, the US drug company that collaborated with Biontech to produce one of the Covid vaccines, wants to minimize its involvement in a'slow and methodical manner' to discourage Haleon's share price from falling. The stake sale by Haleon chiefTobias Hestler is not surprising, considering that the US drug giant has disclosed its intentions for some time.

As he arrived in Davos on Thursday, Pfizer's CEO was befuddled by an aggressive sequence of questions. Albert Bourla remained silent as 'citizen journalists' with microphones followed him through the snowy Swiss streets to ask questions about the COVID-19 vaccine. When asked how long he knew the vaccine did not prevent transmission and how much money he personally earned from its sale, the Pfizer chief remained blank.

The US pharmaceutical giant revealed last month that the price of its shot would rise to $130, if the government uses up the doses it has purchased and the vaccine goes on the open market next year. That represents a 10,000 percent increase from the previous $1.18 it cost the New York City-based firm to produce each dose of the vaccine. Up to this point, the US government has been paying around $30 per dose and then gives the shots for free to the public. Insurers will pay the increased premiums, implying that Americans will not pay up front, but analysts predict that this will result in increased premiums paid by millions of Americans and their families.

David Denton predicted that the Covid virus would be "somewhat like a flu, but more deadly," implying that therapeutics would continue to play a huge role in battling the disease in the United States.